BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 23728341)

  • 1. MicroRNA-29c functions as a tumor suppressor by direct targeting oncogenic SIRT1 in hepatocellular carcinoma.
    Bae HJ; Noh JH; Kim JK; Eun JW; Jung KH; Kim MG; Chang YG; Shen Q; Kim SJ; Park WS; Lee JY; Nam SW
    Oncogene; 2014 May; 33(20):2557-67. PubMed ID: 23728341
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MicroRNA-133b inhibits hepatocellular carcinoma cell progression by targeting Sirt1.
    Tian Z; Jiang H; Liu Y; Huang Y; Xiong X; Wu H; Dai X
    Exp Cell Res; 2016 May; 343(2):135-147. PubMed ID: 27090017
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MiR-29a suppresses cell proliferation by targeting SIRT1 in hepatocellular carcinoma.
    Zhang Y; Yang L; Wang S; Liu Z; Xiu M
    Cancer Biomark; 2018; 22(1):151-159. PubMed ID: 29630527
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MiR-145 functions as a tumor suppressor by directly targeting histone deacetylase 2 in liver cancer.
    Noh JH; Chang YG; Kim MG; Jung KH; Kim JK; Bae HJ; Eun JW; Shen Q; Kim SJ; Kwon SH; Park WS; Lee JY; Nam SW
    Cancer Lett; 2013 Jul; 335(2):455-62. PubMed ID: 23499894
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNA-27b exerts an oncogenic function by targeting Fbxw7 in human hepatocellular carcinoma.
    Sun XF; Sun JP; Hou HT; Li K; Liu X; Ge QX
    Tumour Biol; 2016 Nov; 37(11):15325-15332. PubMed ID: 27704356
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A suppressive role of ionizing radiation-responsive miR-29c in the development of liver carcinoma via targeting WIP1.
    Wang B; Li D; Sidler C; Rodriguez-Juarez R; Singh N; Heyns M; Ilnytskyy Y; Bronson RT; Kovalchuk O
    Oncotarget; 2015 Apr; 6(12):9937-50. PubMed ID: 25888625
    [TBL] [Abstract][Full Text] [Related]  

  • 7. miR-204-5p targeting SIRT1 regulates hepatocellular carcinoma progression.
    Jiang G; Wen L; Zheng H; Jian Z; Deng W
    Cell Biochem Funct; 2016 Oct; 34(7):505-510. PubMed ID: 27748572
    [TBL] [Abstract][Full Text] [Related]  

  • 8. miR-10b exerts oncogenic activity in human hepatocellular carcinoma cells by targeting expression of CUB and sushi multiple domains 1 (CSMD1).
    Zhu Q; Gong L; Wang J; Tu Q; Yao L; Zhang JR; Han XJ; Zhu SJ; Wang SM; Li YH; Zhang W
    BMC Cancer; 2016 Oct; 16(1):806. PubMed ID: 27756250
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA-31 functions as a tumor suppressor by regulating cell cycle and epithelial-mesenchymal transition regulatory proteins in liver cancer.
    Kim HS; Lee KS; Bae HJ; Eun JW; Shen Q; Park SJ; Shin WC; Yang HD; Park M; Park WS; Kang YK; Nam SW
    Oncotarget; 2015 Apr; 6(10):8089-102. PubMed ID: 25797269
    [TBL] [Abstract][Full Text] [Related]  

  • 10. miR-29c Suppresses the Malignant Phenotype of Hepatocellular Carcinoma Cells In Vitro by Mediating TPX2 Associated with Immune Infiltration.
    Wang H; Chen W; Qi Y; Liu D; Liu Z; Zhang Q; Yi Y; Wang J; Wu W
    Dig Dis Sci; 2023 May; 68(5):1923-1935. PubMed ID: 36583803
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel mutation in SIRT1-AS leading to a decreased risk of HCC.
    Liu J; Wu W; Jin J
    Oncol Rep; 2015 Nov; 34(5):2343-50. PubMed ID: 26324025
    [TBL] [Abstract][Full Text] [Related]  

  • 12. miR-29c-3p regulates DNMT3B and LATS1 methylation to inhibit tumor progression in hepatocellular carcinoma.
    Wu H; Zhang W; Wu Z; Liu Y; Shi Y; Gong J; Shen W; Liu C
    Cell Death Dis; 2019 Jan; 10(2):48. PubMed ID: 30718452
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNA-101 inhibits human hepatocellular carcinoma progression through EZH2 downregulation and increased cytostatic drug sensitivity.
    Xu L; Beckebaum S; Iacob S; Wu G; Kaiser GM; Radtke A; Liu C; Kabar I; Schmidt HH; Zhang X; Lu M; Cicinnati VR
    J Hepatol; 2014 Mar; 60(3):590-8. PubMed ID: 24211739
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Growth inhibition of human hepatocellular carcinoma by miRNA-204 via down-regulation of Bcl-2 and Sirt1 expression].
    Li K; Xyu Q; Liu X; Liu Q; Wang M
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2015 Feb; 31(2):168-72. PubMed ID: 25652855
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNA-375 targets AEG-1 in hepatocellular carcinoma and suppresses liver cancer cell growth in vitro and in vivo.
    He XX; Chang Y; Meng FY; Wang MY; Xie QH; Tang F; Li PY; Song YH; Lin JS
    Oncogene; 2012 Jul; 31(28):3357-69. PubMed ID: 22056881
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNA-504 functions as a tumor suppressor in hepatocellular carcinoma through inhibiting Frizzled-7-mediated-Wnt/β-catenin signaling.
    Quan H; Li B; Yang J
    Biomed Pharmacother; 2018 Nov; 107():754-762. PubMed ID: 30142536
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sirtuin 1 is upregulated in a subset of hepatocellular carcinomas where it is essential for telomere maintenance and tumor cell growth.
    Chen J; Zhang B; Wong N; Lo AW; To KF; Chan AW; Ng MH; Ho CY; Cheng SH; Lai PB; Yu J; Ng HK; Ling MT; Huang AL; Cai XF; Ko BC
    Cancer Res; 2011 Jun; 71(12):4138-49. PubMed ID: 21527554
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA-493-5p-mediated repression of the MYCN oncogene inhibits hepatic cancer cell growth and invasion.
    Yasukawa K; Liew LC; Hagiwara K; Hironaka-Mitsuhashi A; Qin XY; Furutani Y; Tanaka Y; Nakagama H; Kojima S; Kato T; Ochiya T; Gailhouste L
    Cancer Sci; 2020 Mar; 111(3):869-880. PubMed ID: 31883160
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reciprocal regulation of microRNA-122 and c-Myc in hepatocellular cancer: role of E2F1 and transcription factor dimerization partner 2.
    Wang B; Hsu SH; Wang X; Kutay H; Bid HK; Yu J; Ganju RK; Jacob ST; Yuneva M; Ghoshal K
    Hepatology; 2014 Feb; 59(2):555-66. PubMed ID: 24038073
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNA-449 suppresses proliferation of hepatoma cell lines through blockade lipid metabolic pathway related to SIRT1.
    Zhang H; Feng Z; Huang R; Xia Z; Xiang G; Zhang J
    Int J Oncol; 2014 Nov; 45(5):2143-52. PubMed ID: 25119660
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.